In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020

体外診断(IVD)の世界市場:体外診断装置、体外診断試薬、体外診断ソフトウェア、サービス

◆タイトル:In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020
◆商品コード:MAM-MD-3609
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年7月22日
◆ページ数:272
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、体外診断(IVD)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、市場シェア分析、製品別分析、技術別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

In vitro diagnostics (IVD) testing is an indispensable tool in the modern medical practice. IVD tests are conducted to diagnose a number of diseases. With the evolution of biotechnology, there has been a drastic change in the type of tests conducted for diagnosing various diseases; this helped physicians across the globe to diagnose and treat diseases promptly and effectively. The increasing usage of self-testing kits is the most important trend witnessed recently in the IVD industry is that of

The global IVD market is expected to reach USD 75.1 billion by 2020, growing at a CAGR of 5.8% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of chronic lifestyle diseases in emerging economies, growing aging population, and rising adoption of point-of-care testing and personalized medicine.

In this report, the market is segmented by product, technology, application, end user, and region. The IVD market, by product, is segmented into reagents and kits, instruments, services, and data management system/software. In 2014, the reagents and kits segment accounted for the largest share of approximately 79.3% of the IVD product market, and is expected to grow at a CAGR of 6.4% during the forecast period. Growth in this segment is mainly attributed to the increasing demand for diagnostic tests and launch of new reliable, specific, and faster detection reagents.

On the basis of applications, the IVD market is segmented into diabetes, infectious diseases, oncology, cardiology, HIV/AIDS, autoimmune diseases, drug testing, nephrology, and other applications. The oncology segment is expected to grow at the highest CAGR of 9.6% during the forecast period, owing to the increasing number of cancer patients across the world.

In 2014, North America commanded the largest share of the global IVD market, followed by Europe, Asia-Pacific, and the RoW. North America accounted for the largest share of 42.5% of global IVD market in 2014. The U.S. is a prime market due to the availability of government funds, expansion of molecular diagnostics for genetic disorders and cancer screening, and easy access to IVD tests through diagnostic service providers and major leading companies headquartered in the U.S. On the other hand, Asia-Pacific is the fastest-growing region in the global IVD market, mainly driven by the increasing demand for IVD tests from large patient population, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investment by leading players and respective government agencies in the region.

The major players in the IVD market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Ortho-Clinical Diagnostics (U.S.), Johnson and Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), and bioMérieux (France).

[Reasons to Buy the Report]

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by top players in the IVD market. The report analyzes the IVD market by product, technology, end user, and application across all regions
• Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the IVD market
• Market Development: Comprehensive information on the lucrative emerging markets by product, technology, end user, application, and region
• Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the IVD market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of leading players in the IVD market

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 31)
4.1 Growth Potential of the IVD Market
4.2 North America: IVD Market
4.3 IVD Market: Geographic Snapshot
4.4 Geographic Mix: IVD Market, By Technology
4.5 IVD Market: Emerging vs Developed Markets

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Segmentation
5.2.1 In Vitro Diagnostics Market, By Product
5.2.2 In Vitro Diagnostics Market, By Technology
5.2.3 In Vitro Diagnostics Market, By Application
5.2.4 In Vitro Diagnostics Market, By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Incidence of Chronic Lifestyle Diseases Across the Globe
5.3.1.2 Rapid Growth in the Geriatric Population
5.3.1.3 Increasing Adoption of Point-Of-Care (POC) Testing
5.3.1.4 Growing Awareness of Personalized Medicine
5.3.2 Restraints
5.3.2.1 Inadequate Reimbursement
5.3.2.2 Implementation of Excise Duty By the U.S. Government
5.3.3 Opportunities
5.3.3.1 New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.3.3.2 Emerging Economies With Increasing Investments
5.3.4 Challenges
5.3.4.1 Stringent Regulatory Framework

6 Industry Insights (Page No. – 48)
6.1 Introduction
6.2 Industry Trends
6.3 Porter’s Five Force Analysis
6.3.1 Threat From New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Regulatory Analysis
6.4.1 North America
6.4.1.1 U.S.
6.4.1.2 Canada
6.4.2 Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India
6.4.3.4 Australia

7 Global IVD Market, By Product & Service (Page No. – 57)
7.1 Introduction
7.2 Reagents & Kits
7.3 Instruments
7.4 Data Management Software/Hardware
7.5 Services

8 Global IVD Market, By Technology (Page No. – 69)
8.1 Introduction
8.2 Clinical Chemistry
8.2.1 Basic Metabolic Panel
8.2.2 Electrolyte Panels
8.2.3 Liver Panels
8.2.4 Lipid Profiles
8.2.5 Renal Profiles
8.2.6 Thyroid Function Panels
8.2.7 Specialty Chemical Tests
8.3 Immunochemistry/Immunoassays
8.3.1 Elisa
8.3.1.1 Chemiluminescence Immunoassays (CLIAs)
8.3.1.2 Fluorescence Immunoassays (FIA)
8.3.1.3 Colorimetric Immunoassays (CI)
8.3.2 Radioimmunoassays (RIA)
8.3.3 Rapid Tests
8.3.4 Western Blot
8.3.5 Elispot
8.4 Hematology
8.5 Coagulation and Hemostasis
8.6 Microbiology
8.7 Molecular Diagnostics (MDX)
8.7.1 Polymerase Chain Reaction (PCR)
8.7.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.7.3 Microarrays
8.7.4 Hybridization
8.7.5 Dna Sequencing & Next-Generation Sequencing
8.7.6 Others
8.8 Others

9 In Vitro Diagnostics Market, By Application (Page No. – 121)
9.1 Introduction
9.2 Diabetes
9.3 Infectious Diseases
9.4 Oncology/Cancer
9.5 Cardiology
9.6 Nephrology
9.7 Autoimmune Diseases
9.8 Drug Testing
9.9 HIV/AIDS
9.1 Other Applications

10 Global IVD Market, By End User (Page No. – 141)
10.1 Introduction
10.2 Laboratories
10.3 Hospitals
10.4 Academic Institutes
10.5 Point-Of-Care Testing
10.6 Patient Self-Testing
10.7 Others

11 Geographic Analysis Key Findings (Page No. – 153)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Russia
11.3.7 Rest of Europe (RoE)
11.4 Asia-Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.1.1 Brazil
11.5.1.2 Mexico
11.5.1.3 Rest of Latin America (RoLA)
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 230)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.4 New Product Launches
12.5 Agreements, Partnerships, and Collaborations
12.6 Mergers and Acquisitions
12.7 Expansions

13 Company Profiles (Page No. – 237)
13.1 Abbott Laboratories, Inc.
13.1.1 Business Overview
13.1.2 Products Offered
13.1.3 Services Offered
13.1.4 Recent Developments
13.1.5 MnM View
13.2 Roche Diagnostics
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 Biomérieux
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.4 Ortho Clinical Diagnostics, Inc.
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Services Offered
13.5.4 Recent Developments
13.6 Danaher Corporation
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Services Offered
13.6.4 Recent Developments
13.6.5 MnM View
13.7 Johnson and Johnson
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.7.4 MnM View
13.8 Siemens Healthcare
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Services Offered
13.8.4 Recent Developments
13.8.5 MnM View
13.9 Sysmex Corporation
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Services Offered
13.9.4 Recent Developments
13.10 Becton, Dickinson and Company
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Thermo Fisher Scientific, Inc.
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Services Offered
13.11.4 Recent Developments

14 Appendix (Page No. – 296)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 O Ther Developments, 2012–2015
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports

List of Tables (162 Tables)

Table 1 Increased Incidence of Chronic Lifestyle Diseases and Rapid Growth in Geriatric Population Will Drive the Market Growth
Table 2 Lack of Budget and Implementation of Excise Duty to Restrain the Market Growth
Table 3 Emerging Economies With Increasing Investments Offer Significant Opportunities for Market Growth
Table 4 Stringent Regulatory Framework is A Major Challenge
Table 5 Global In Vitro Diagnostics Market, By Product & Service, 2013–2020 (USD Million)
Table 6 Global In Vitro Diagnostics Reagents & Kits Market Size, By Country, 2013–2020 (USD Million)
Table 7 Global In Vitro Diagnostics Reagents & Kits Market Size, By Technology, 2013–2020 (USD Million)
Table 8 Global In Vitro Diagnostics Instruments Market Size, By Country, 2013–2020 (USD Million)
Table 9 Global IVD Instruments Market Size, By Technology, 2013–2020 (USD Million)
Table 10 Global Data Management System Software/Hardware Market Size, By Country, 2013–2020 (USD Million)
Table 11 Global IVD Data Management System Software/Hardware Market Size, By Technology, 2013–2020 (USD Million)
Table 12 Global In Vitro Diagnostics Services Market Size, By Country, 2013–2020 (USD Million)
Table 13 Global IVD Services Market Size, By Technology, 2013–2020 (USD Million)
Table 14 Global In Vitro Diagnostics Market, By Technology, 2013 – 2020 (USD Million)
Table 15 Global Clinical Chemistry Market Size, By Country, 2013–2020 (USD Million)
Table 16 Global Clinical Chemistry Market Size, By Test, 2013–2020 (USD Million)
Table 17 Global Basic Metabolic Panels Market Size, By Country, 2013–2020 (USD Million)
Table 18 Global Electrolyte Panels Market Size, By Country, 2013–2020 (USD Million)
Table 19 Global Liver Panels Market Size, By Country, 2013–2020 (USD Million)
Table 20 Global Lipid Profiles Market Size, By Country, 2013–2020 (USD Million)
Table 21 Global Renal Profiles Market Size, By Country, 2013–2020 (USD Million)
Table 22 Global Thyroid Function Panels Market Size, By Country, 2013–2020 (USD Million)
Table 23 Global Specialty Chemical Tests Market Size, By Country, 2013–2020 (USD Million)
Table 24 Global Immunoassay/Immunochemistry Market Size, By Type, 2013–2020 (USD Million)
Table 25 Global Immunoassay/Immunochemistry Market Size, By Country, 2013–2020 (USD Million)
Table 26 Global Elisa Market Size, By Country, 2013–2020 (USD Million)
Table 27 Global Chemiluminescence Immunoassays (CLIA) Market Size, By Country, 2013–2020 (USD Million)
Table 28 Global Fluorescence Immunoassays Market Size, By Country, 2013–2020 (USD Million)
Table 29 Global Colorimetric Immunoassays Market Size, By Country, 2013–2020 (USD Million)
Table 30 Global Radioimmunoassays Market Size, By Country, 2013–2020 (USD Million)
Table 31 Global Rapid Tests Market Size, By Country, 2013–2020 (USD Million)
Table 32 Global Western Blot Market Size, By Country, 2013–2020 (USD Million)
Table 33 Global Elispot Market Size, By Country, 2013–2020 (USD Million)
Table 34 Global Hematology Market Size, By Country, 2013–2020 (USD Million)
Table 35 Global Coagulation & Hemostasis Market Size, By Country, 2013–2020 (USD Million)
Table 36 Global Microbiology Market Size, By Country, 2013–2020 (USD Million)
Table 37 Global Molecular Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 38 Global Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 39 Global PCR Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 40 Global INAAT Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 41 Global Microarrays Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 42 Global Hybridization Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 43 Global Dna Sequencing & Ngs Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 44 Global Other Technologies Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 45 Global Other Technologies Market Size, By Country, 2013–2020 (USD Million)
Table 46 Global In Vitro Diagnostics Market Size, By Application, 2013 – 2020 (USD Million)
Table 47 Global Diabetic Patient Population (2014)
Table 48 Global Market Size for Diabetes, By Country, 2013–2020 (USD Million)
Table 49 Global In Vitro Diagnostics Market Size for Infectious Diseases, By Country, 2013–2020 (USD Million)
Table 50 Global In Vitro Diagnostics Market Size for Oncology, By Country, 2013–2020 (USD Million)
Table 51 Global Market Size for Cardiology, By Country, 2013–2020 (USD Million)
Table 52 Global Market Size for Nephrology, By Country, 2013–2020 (USD Million)
Table 53 Global In Vitro Diagnostics Market Size for Autoimmune Diseases, By Country, 2013–2020 (USD Million)
Table 54 Global Market Size for Drug Testing, By Country, 2013–2020 (USD Million)
Table 55 Global In Vitro Diagnostics Market Size for HIV/AIDS, By Country, 2013–2020 (USD Million)
Table 56 Global Market Size for Other Applications, By Country, 2013–2020 (USD Million)
Table 57 Global Market, By End User, 2013–2020 (USD Million)
Table 58 Global IVD Market Size for Laboratories, By Country, 2013–2020 (USD Million)
Table 59 Global In Vitro Diagnostics Market Size for Hospitals, By Country, 2013–2020 (USD Million)
Table 60 Global In Vitro Diagnostics Market Size for Academic Institutes, By Country, 2013–2020 (USD Million)
Table 61 Global Market Size for POC Testing, By Country, 2013–2020 (USD Million)
Table 62 Global In Vitro Diagnostics Market Size for Patient Self-Testing, By Country, 2013–2020 (USD Million)
Table 63 Global Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 64 Global Market Size, By Region, 2013–2020 (USD Million)
Table 65 Global In Vitro Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 66 North America: In Vitro Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 67 North America: IVD Market Size, By Product Type, 2013–2020 (USD Million)
Table 68 North America: In Vitro Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 69 North America: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 70 North America: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 71 U.S.: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 72 U.S.: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 73 U.S.: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 74 U.S.: In Vitro Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 75 Canada: IVD Market Size, By Product Type, 2013–2020 (USD Million)
Table 76 Canada: In Vitro Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 77 Canada: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 78 Canada: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 79 Europe: In Vitro Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 80 Europe: IVD Market Size, By Product Type, 2013–2020 (USD Million)
Table 81 Europe: In Vitro Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 82 Europe: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 83 Europe: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 84 Germany: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 85 Germany: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 86 Germany: In Vitro Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 87 Germany: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 88 France: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 89 France: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 90 France: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 91 France: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 92 U.K.: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 93 U.K.: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 94 U.K.: In Vitro Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 95 U.K.: In Vitro Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 96 Italy: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 97 Italy: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 98 Italy: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 99 Italy: In Vitro Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 100 Spain: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 101 Spain: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 102 Spain: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 103 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 104 Russia: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 105 Russia: Market Size, By Application, 2013–2020 (USD Million)
Table 106 Russia: In Vitro Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 107 Russia: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 108 RoE: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 109 RoE: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 110 RoE: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 111 RoE: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 112 APAC: In Vitro Diagnostics Market Size, By Country, 2013-2020 (USD Million)
Table 113 APAC: Market Size, By Product Type, 2013-2020 (USD Million)
Table 114 APAC: Market Size, By Application, 2013-2020 (USD Million)
Table 115 APAC: In Vitro Diagnostics Market Size, By Technology, 2013-2020 (USD Million)
Table 116 APAC: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 117 Japan: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 118 Japan: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 119 Japan: Market Size, By Technology, 2013-2020 (USD Million)
Table 120 Japan: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 121 China: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 122 China: Market Size, By Application, 2013-2020 (USD Million)
Table 123 China: In Vitro Diagnostics Market Size, By Technology, 2013-2020 (USD Million)
Table 124 China: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 125 India: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 126 India: Market Size, By Application, 2013-2020 (USD Million)
Table 127 India: Market Size, By Technology, 2013-2020 (USD Million)
Table 128 India: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 129 RoAPAC: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 130 RoAPAC: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 131 RoAPAC: IVD Market Size, By Technology, 2013-2020 (USD Million)
Table 132 RoAPAC: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 133 RoW: In Vitro Diagnostics Market Size, By Region, 2013-2020 (USD Million)
Table 134 RoW: Market Size, By Product Type, 2013-2020 (USD Million)
Table 135 RoW: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 136 RoW: Market Size, By Technology, 2013-2020 (USD Million)
Table 137 RoW: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 138 Latin America: In Vitro Diagnostics Market Size, By Country, 2013-2020 (USD Million)
Table 139 Latin America: IVD Market Size, By Product Type, 2013-2020 (USD Million)
Table 140 Latin America: In Vitro Diagnostics Market Size, By Application, 2013-2020 (USD Million)
Table 141 Latin America: Market Size, By Technology, 2013-2020 (USD Million)
Table 142 Latin America: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 143 Brazil: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 144 Brazil: Market Size, By Application, 2013-2020 (USD Million)
Table 145 Brazil: Market Size, By Technology, 2013-2020 (USD Million)
Table 146 Brazil: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 147 Mexico: In Vitro DiagnosticsMarket Size, By Product Type, 2013-2020 (USD Million)
Table 148 Mexico: Market Size, By Application, 2013-2020 (USD Million)
Table 149 Mexico: Market Size, By Technology, 2013-2020 (USD Million)
Table 150 Mexico: In Vitro Diagnostics Market Size, By End User, 2013-2020 (USD Million)
Table 151 RoLA: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 152 RoLA: Market Size, By Application, 2013-2020 (USD Million)
Table 153 RoLA: Market Size, By Technology, 2013-2020 (USD Million)
Table 154 RoLA: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 155 Middle East and Africa: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 156 Middle East and Africa: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 157 Middle East and Africa: In Vitro Diagnostics Market Size, By Technology, 2013-2020 (USD Million)
Table 158 Middle East and Africa: In Vitro Diagnostics Market Size, By End User, 2013-2020 (USD Million)
Table 159 New Product Launches, 2012–2015
Table 160 Agreements, Partnerships, and Collaborations, 2012–2015
Table 161 Mergers and Acquisitions, 2012–2015
Table 162 Expansions, 2012–2015

List of Figures (44 Figures)

Figure 1 Global in Vitro Diagnostics Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global In Vitro Diagnostics Market Size, By Products & Services, 2015 vs 2020 (USD Million)
Figure 8 Global IVD Market Size, By Application, 2015 vs 2020 (USD Million)
Figure 9 Global IVD Market Size, By End User, 2015 vs 2020 (USD Million)
Figure 10 IVD Market: Geographic Snapshot
Figure 11 High Growth Potential of Asia-Pacific Provides Significant Opportunities for the Market
Figure 12 Increasing Incidence of Chronic Lifestyle Diseases is Driving Growth in the IVD Market
Figure 13 Reagents & Kits to Account for the Largest Share of the IVD Market in North America
Figure 14 U.S. to Command More Than One-Third of the Global IVD Market
Figure 15 North America to Dominate the Molecular Diagnostics & Microbiology Markets
Figure 16 Emerging Markets are Estimated to Grow at A Higher Rate During the Forecast Period
Figure 17 In Vitro Diagnostics Market Segmentation, By Product
Figure 18 In Vitro Diagnostics Market Segmentation, By Technology
Figure 19 In Vitro Diagnostics Market Segmentation, By Application
Figure 20 In Vitro Diagnostics Market Segmentation, By End User
Figure 21 IVD Market: Drivers, Restraints, Opportunities, & Challenges
Figure 22 Major Trend: Acquisitions Resulting in Market Consolidation
Figure 23 Regulatory Approval Process in China
Figure 24 Regulatory Approval Process in India
Figure 25 Reagents, the Fastest Growing Segment of the IVD Market
Figure 26 Molecular Diagnostics Will Grow at the Highest Cagr During the Forecast Period of 2015-2020
Figure 27 Oncology is the Fastest-Growing Segment of the IVD Market
Figure 28 North America to Dominate the IVD Market
Figure 29 North American IVD Market Overview
Figure 30 European IVD Market Overview
Figure 31 Players Majorly Adopted the Strategy of New Product Launches From 2012 to 2015
Figure 32 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2014
Figure 33 Battle for Market Share: New Product Launches Was the Key Strategy
Figure 34 Geographic Revenue Mix of the Top 5 Market Players
Figure 35 Company Snapshot: Abbott Laboratories, Inc.
Figure 36 Company Snapshot: F. Hoffmann-La Roche Ltd.
Figure 37 Company Snapshot: Biomérieux
Figure 38 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 39 Company Snapshot: Danaher Corporation
Figure 40 Company Snapshot: Johnson and Johnson
Figure 41 Company Snapshot: Siemens AG
Figure 42 Company Snapshot: Sysmex Corporation
Figure 43 Company Snapshot: Becton, Dickinson and Company
Figure 44 Company Snapshot: Thermo Fisher Scientific, Inc.

【レポートのキーワード】

体外診断(IVD)、体外診断装置、体外診断試薬、体外診断ソフトウェア、サービス、体外診断キット、体外診断技術、臨床化学、免疫化学、分子診断、血液科

★調査レポート[体外診断(IVD)の世界市場:体外診断装置、体外診断試薬、体外診断ソフトウェア、サービス] ( In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020 / MAM-MD-3609) 販売に関する免責事項
[体外診断(IVD)の世界市場:体外診断装置、体外診断試薬、体外診断ソフトウェア、サービス] ( In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020 / MAM-MD-3609) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆